ESPR Operating Expenses

Esperion Therapeutics Inc · Operating Expenses

ESPR logo

ESPR Operating Expenses

Latest reported$52.11M
ESPR Quarterly Operating Expenses ($5.47M → $52.11M)
High-resolution chart · PNG

ESPR operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Esperion Therapeutics Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
52,112,000
55,359,000
41,848,000
46,747,000
55,553,000
47,902,000
50,372,000
55,646,000
55,391,000
63,165,000
48,125,000
56,058,000
61,282,000
57,171,000
54,097,000
62,041,000
54,700,000
65,954,000
64,596,000
71,392,000
89,018,000
103,519,000
84,109,000
82,668,000
76,255,000
59,946,000
66,749,000
56,280,000
58,490,000
60,649,000
50,562,000
46,480,000
46,894,000
38,696,000
45,737,000
43,660,000
40,889,000
29,285,000
17,712,000
14,331,000
14,822,000
13,234,000
12,919,000
12,462,000
11,425,000
9,380,000
9,700,000
9,254,000
7,890,000
9,736,016
5,406,823
4,271,847
3,344,012
2,160,047
2,990,249
2,863,881
2,189,583
6,457,000
8,153,000
7,405,000
6,467,000
7,383,000
7,676,000
7,711,000
6,456,000
7,259,000
8,196,000
8,347,000
6,242,000
7,820,000
7,252,000
5,474,128
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.